Cancer Research Technology
Log in Register
Menu

Anti-CD13 [22A5]

Invented at Queen Mary University of London

Info

Catalogue Number 152690
Applications FACS IHC IP
Antigen/Gene or Protein Targets Aminopeptidase N (CD13)
Synonyms Alanyl Aminopeptidase; Membrane; Microsomal Aminopeptidase; Aminopeptidase M; Myeloid Plasma Membrane Glycoprotein CD13; GP150; CD13; PEPN
Reactivity Human
Relevance Aminopeptidase N (CD13) is a cell-surface metalloprotease involved in the metabolism of regulatory peptides. 22A5 may be useful for the diagnosis and immunophenotyping of leukaemia.
Host Mouse
Immunogen A cell suspension containing osteoclasts from osteoclastomas.
Positive Control Cells of myelomonocytic lineage
Subclass IgG2a kappa
Recommended Growing Conditions DMEM + 5% FCS
Strain Balb/c
Research Area Cancer, Cell Type or Organelle Marker, Metabolism, Protein Degradation, Stem Cell Biology

References

There are 10 reference entries for this reagent.

View All References

References: 10 entries

Murray et al. 1995. Leuk Lymphoma. 17(5-6):501-8. PMID: 7549844.

Immunocytochemical studies of an antigen in a human T-cell lymphoma line (Jurkat) recognized by certain monoclonal antibodies to CD-13 (aminopeptidase-N).

Europe PMC ID: 7549844

van Hal et al. 1994. J Immunol. 153(6):2718-28. PMID: 7915741.

Potential indirect anti-inflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC 3.4.11.2).

Europe PMC ID: 7915741

Ashmun et al. 1990. Blood. 75(2):462-9. PMID: 1967220.

Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.

Europe PMC ID: 1967220

Look et al. 1989. J Clin Invest. 83(4):1299-307. PMID: 2564851.

FACS

Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N.

Europe PMC ID: 2564851

Horton et al. 1985. Cancer Res. 45(11 Pt 2):5663-9. PMID: 4053038.

Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens.

Europe PMC ID: 4053038


Add a reference

References: 10 entries

Murray et al. 1995. Leuk Lymphoma. 17(5-6):501-8. PMID: 7549844.

Immunocytochemical studies of an antigen in a human T-cell lymphoma line (Jurkat) recognized by certain monoclonal antibodies to CD-13 (aminopeptidase-N).

van Hal et al. 1994. J Immunol. 153(6):2718-28. PMID: 7915741.

Potential indirect anti-inflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC 3.4.11.2).

Ashmun et al. 1990. Blood. 75(2):462-9. PMID: 1967220.

Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.

Look et al. 1989. J Clin Invest. 83(4):1299-307. PMID: 2564851.

FACS

Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N.

Horton et al. 1985. Cancer Res. 45(11 Pt 2):5663-9. PMID: 4053038.

Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor